Makers Laboratories share news, announcements and annual reports
NSE: MAKERSLBSE: 506919Pharmaceuticals & BiotechnologySmall Cap
Makers Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1985
Last close ₹192.45up ₹3.27 (1.73%)BSE ₹190.05
Share price at the NSE close on 29 Oct 2026. Previous close ₹189.18.
29 Oct: open ₹188.24, high ₹197.50, low ₹188.24
52-week range of BSE trades to 29 Oct 2026
₹109.00Low, 22 Dec 2025₹239.00High, 21 Oct 2026
- Next results date: the board meets on 4 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹114 Cr3,027th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.21
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,18184.1% delivered
Makers Laboratories board meetings
99 filed, newest first. Page 2 of 2.
May 2022
2 May · Board meeting
Meeting on 6 May 2022: rights issue
Jan 2022
25 Jan · Board meeting
Meeting on 9 Feb 2022: quarterly results
Nov 2021
Oct 2021
29 Oct · Board meeting
Meeting on 10 Nov 2021: rights issue of equity shares and quarterly results
Aug 2021
Jul 2021
30 Jul · Board meeting
Meeting on 13 Aug 2021: quarterly results
May 2021
25 May · Board meeting
Meeting on 10 Jun 2021: audited results
Jan 2021
22 Jan · Board meeting
Meeting on 10 Feb 2021: quarterly results
Oct 2020
26 Oct · Board meeting
Meeting on 4 Nov 2020: quarterly results
Sep 2020
24 Sep · Board meeting
Meeting on 24 Sep 202024 Sep · Board meeting
Jul 2020
29 Jul · Board meeting
Meeting on 12 Aug 2020: quarterly results
Jun 2020
5 Jun · Board meeting
Meeting on 15 Jun 2020: audited results
Jan 2020
20 Jan · Board meeting
Meeting on 6 Feb 2020: quarterly results
Oct 2019
23 Oct · Board meeting
Meeting on 6 Nov 2019: quarterly results
Jul 2019
22 Jul · Board meeting
Meeting on 8 Aug 2019: quarterly results
May 2019
8 May · Board meeting
Meeting on 22 May 2019: audited results and final dividend
Jan 2019
22 Jan · Board meeting
Meeting on 13 Feb 2019: quarterly results
Oct 2018
May 2018
Jan 2018
29 Jan · Board meeting
Nov 2017
14 Nov · Board meeting
Oct 2017
27 Oct · Board meeting
May 2016
19 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 27, 2016, inter alia, to consider: 1. the Audited Financial Results ....
Apr 2016
Feb 2016
May 2015
15 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 29, 2015, inter-alia, to consider: 1. The Audited Financial Results ....
May 2014
27 May · Board meeting
May 2011
9 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 20, 2011, inter-alia, to consider : 1. The Audited Financial ....
Aug 2010
12 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 12, 2010, inter alia, has approved amalgamation of Harleystreet Pharmaceuticals ....
May 2010
18 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 31, 2010, inter alia, to consider: 1. the Audited Financial Results ....